18
Applying biofluid 1 H NMR-base metabo nomic techniques to distinguish between HIV-1 positive/AIDS patients on ant iretroviral treatment and HIV-1 neg ative individuals 应应 1 H NMR 应应应应应应应应应应应 应应应应 体体 应应应 HIV-1 应应应应应应应应应应应应应应应应应 应 HIV-1 应应应应应 2007 应 11 应 27 应

Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Embed Size (px)

Citation preview

Page 1: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Applying biofluid 1H NMR-base metabonomic techniques to distinguish between

HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals

应用 1H NMR 基于代谢组学技术分析人体内的液体来区分 HIV-1 阳性或用抗反转录病毒治疗的爱滋病人

和 HIV-1 阴性的病人

龙 传 南 2007 年 11 月 27 日

Page 2: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

文章来源 :Journal of Pharmaceutical and Biomedical Analysis 41 (2006) 1442–1446

作者 : R. Hewer, J. Vorster, F.E. Steffens,

D. Meyera,∗

Page 3: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Abstract ( 摘 要 )

※ Metabonomics, the study of metabolites and their role in various physiological states, is a novel methodology arising from the post-genomics era and has extensive biomedical application. This technology has exhibited vast success in the identification and study of human diseases and may find further application in the study of HIV/AIDS. Specifically, the wide range of clinical and metabolic abnormalities associated with the use of antiretroviral (ARV) treatment may be investigated.

※ To this end, this preliminary study evaluated whether metabonomic techniques could distinguish between HIV-1 positive/AIDS patients utilizing antiretroviral therapy and HIV-1 negative individuals. Serum metabolic profiles determined by 1H nuclear magnetic resonance (NMR) spectroscopy combined with pattern recognition analysis of the data showed that this distinction was attainable;suggesting that ARV-associated side-effects could be monitored utilizing NMRmetabonomic techniques.

Page 4: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Introduction ( 引 言 )

1 、 1H NMR spectroscopy of biofluids (urine, serum/plasma)and tissue generates comprehensive biochemical profiles of low molecular weight endogenous metabolites 。

2 、 Metabonomics have been applied to both diseased and healthy 。

3 、 Notable metabonomic applications include the distinction between type 2 diabetic patients and healthy volunteers , diagnosis of coronary heart disease and investigation of hypertension 。

Page 5: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

4 、 1H NMR spectroscopy-based metabonomics could find extensive application in the monitoring of the biological side-effects of antiretroviral

s used for the therapeutic treatment of HIV/AIDS. A wide range of clinical and metabolic complications are associated with the use of anti-retroviraltreatment; including lipodystropy syndromes, hyperlipidaemia,insulin resistance and hyperglycemia 。 Metabolic disorders of HIV positive/AID

S patients 1H NMR spectroscopy may potentially monitor and correlatemetabolic disorders and contribute knowledge to the study of the adverse side-effects caused by antiretroviral therapy.

5 、 To this end,this preliminary study demonstrated that distinction could be made between HIV-1 positive/AIDS patients utilizing antiretroviraltherapy and HIV-1 negative individuals based on 1H NMR metabolic profiles. Samples from HIV/AIDS patients not using antiretrovirals were included to illustrate that this distinctionwas based on the use of ARV’s.

Page 6: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Materials and methods( 材料和方法 )

※ Sample collection The first group( 第一组 ): 34 HIV-1 positive patients.

29 patients were undergoing treatment with combination antiretroviral therapy while 5 patients had not previously utilized antiretroviral agents.

The second group( 第二组 ): 29 HIV-1 negative laboratory personnel.

Blood( 血液 ) Serum( 血清 )

Page 7: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

※ 1H NMR spectroscopy1. Serum samples (150 ) were diluted with 500 of 52%

D2O and 0.5% NaCl and placed in 5mm high quality NMR tubes.

2. Measured at 300MHz on a Varian Unity Inova using an IDG300-5EHT indirect detection gradient probe. The following pulse sequence was used: 90◦–90◦–RD–satdly–tm–90◦- acquire free induction decay (FID). RD represents a relaxation delay of 3.0 s, satdly was 1.5 s during which the water resonance was selectively irradiated,and the mixing time (tm) was 0.4 ms.

3. For each sample,640 FIDS were collected with a spectral width of 4001.6 Hz and an acquisition time of 3.744 s. The acquired NMR spectra were collected for phase and baseline distortions and referenced to lipid CH2C=C at 1.89 ppm.

Page 8: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

※ Data reduction of NMR data The 1H NMR spectra obtained for each serum sample (δ4.0–0.4 ppm) were automatically data reduced to 120 Integral segments of equal length (δ 0.03 ppm). Each segment consisted of the integral of the NMR region to which it was associated.

Although the area in the suppression of the water resonance was not included, the region δ 6.0–4.4 was set to zero integral.

Page 9: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

※ Statistical analysis ( 统计分析 )

1. Standardization of the data ( 数据标准化 )

计算出每个样品的平均数和标准差 , 再减去每个样品振幅( 峰高 ) 的平均数 , 然后分类 , 根据标准差 :

where is the amplitude at frequency f for the ith individual; is the mean value of the 120 amplitudes for the ith individual; is the standard deviation of the 120 amplitudes for the ith individual; is the standardized amplitude at frequency f for the ith individual.

The result was that the standardized spectra for each individualhad a mean of 0 and a standard deviation of 1.

Page 10: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

2. Analysis of variance (ANOVA) ( 方差分析 )

什么是方差分析:方差分析( ANOVA )又称变异数分析或 F 检验,其

目的是推断两组或多组资料的总体均数是否相同,检验两个或多个样本均数的差异是否有统计学意义。所获得的数据按某些项目分类后,再分析各组数据之间有无差异的方法。一般一组数据代表某个条件或因素,方差分析可以判断你选取的这个因素是否有意义,是不是影响因素。如果你做统计为了找到事物相关性,而方差结果显示数据无统计学差异,很可能代表实验失败或设计有问题。

Comparison of the mean standardized spectra of the two groups was done by means of analysis of variance F-tests. This was done inorder to establish whether or not there were significant differences between the groups. Only cases where the significance level (p-value) was less than 0.01 were considered.

Page 11: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

3. Discriminant analysis (辨别分析) 什么是辨别分析:辨别分析是用某种方法将研究对象分成若干类的前提下,建立辨别函数,用以判定未知对象属于已知分类中的哪一类。即事先提出其他标准的两个以上群的已测知的多变量性状的标本时,则手中欠明的新标本应归属于何群,便可通过多变量的性状线索来进行辨别。对辨别分析可通过最有效的线性函数即辨别函数( discriminant function )来计算。

Linear discriminant analysis (LDA) was applied in order to classify acase as HIV positive using ARV’s, HIV positive not using ARV’s or HIVnegative, given the NMR spectrum (standardized, as described above). Because there were amplitudes at 120 frequencies available, and using all of them would amount to gross overfitting, stepwise discriminant analysis was used to select the best set of frequencies for the classification.The resultant classification was based on 21 of the spectrum amplitudes. A cross-validation was done in which each case was omitted in turn from the analysis and then classified using the analysis based on the other 62 cases. The two discriminant functions, produced by this analysis, were plotted on a scatter diagram

Page 12: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

Results and discussion( 结果和讨论 )

Page 13: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

1 、 Results from this study suggest that distinction between the two sample groups is achievable

2 、 The natural homeostatic control of serum was evident as spectra from the two populations exhibited similar peaks.

3 、 Results from the ANOVA analysis showed that the serum spectra of treated HIV positive/AIDS patients were discernable from those of healthy HIV-1 negative individuals. As stated previously, the NMR spectra for each serum sample were automatically data reduced to 120 integral segments of equal length.

4 、 Of these 120 segments, exactly 30 were identified through ANOVA analysis as significantly dissimilar (p < 0.01). Many of these segments were adjacent to each other, for example each 0.03 ppm segment between 2.725 and 2.425 ppm was identified as significantly different between the two populations. Imposing a criterion of p < 0.000, 8 segments were identified as exhibiting the most variation between the two spectra and are denoted in Fig. 1 by asterisks.

5 、 The chemical content comprising some of these segments correlate with known metabolic irregularities of HIV/AIDS patients using antiretroviral drugs, i.e. the peaks within the segments contain lipids and glucose which are chemical compounds associated with ARV-associated disorders of lipodystrophy, Hyperlipidaemia and hyperglycemia

Page 14: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative
Page 15: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative
Page 16: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

1 、 Linear discriminant analysis was then applied to the data in order to determine whether the samples could be classified as HIV positive or HIV negative.

2 、 The resulting scatter diagram of the discriminant functions (Fig. 2) shows that the five HIV-1 cases without ARV treatment are separated from the other two groups on the vertical axis (the first discriminant function), while on the horizontal axis(the second discriminant function) the HIV-1 positive patients on ARV treatment and the HIV-1 negative patients are separated with the HIV-1 positive patients not on ARV treatment betweenthese two groups.

3 、 It is noticeable that one HIV negative case appears closer to the group of HIV positive individuals on ART.The individual in this case was not HIV positive at the time of testing, nor 3 months later when re-tested. The individual had no known metabolic or other medical condition and further investigation is underway to determine the underlying cause of this anomaly.

4 、 The five HIV positive samples not on ARV treatment were included to illustrate that distinction can be made based on the use of ARV’s. Although not the main focus of this study and using a small data set, these observations may also suggest the possibility of studying metabolic irregularities unrelated to anti-retroviral use.

Page 17: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

展望 :1 、 NMR 用于研究代谢组学的频率一般 600MHz ,

而在这个研究中用 300MHz 。因为在 300MHz 的频率下具有比 600MHz 有更高的分辨率。

2 、通过代谢和化学计量分析可以监测 HIV/AIDS patients on antiretroviral Therapy 。进一步可以用于研究抗反转录病毒治疗和纠正代谢紊乱。

Page 18: Applying biofluid 1 H NMR-base metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative

谢 谢 !